EFFICACY AND SAFETY ASSESSMENT OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO INHALED CORTICOSTEROIDS IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA

被引:0
|
作者
Hamelmann, E. [1 ]
Boner, A. [2 ]
Bernstein, J. [3 ]
Moroni-Zentgraf, P. [4 ]
Engel, M. [4 ]
Avis, M. [5 ]
Unseld, A. [6 ]
Vandewalker [7 ]
机构
[1] Ruhr Univ Bochum, Klin Kinder & Jugendmed, Bochum, Germany
[2] Univ Verona, Dept Pediat, I-37100 Verona, Italy
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[5] Boehringer Ingelheim Bv, Alkmaar, Netherlands
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Clin Applicat, Biberach, Germany
[7] Clin Res Ozarks, Columbia, MO USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
54
引用
收藏
页码:S55 / S55
页数:1
相关论文
共 50 条
  • [21] Once-daily Tiotropium Respimat® Add-on Therapy Improves Lung Function and Control in Adolescents and Children with Moderate Symptomatic Asthma
    Vogelberg, Christian
    Hamelmann, Eckard
    Szefler, Stanley J.
    El Azzi, Georges
    Moroni-Zentgraf, Petra
    Engel, Michael
    Sigmund, Ralf
    Vandewalker, Mark L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB95 - AB95
  • [22] Once-daily tiotropium respimat add-on to ICS±LABA improves control across asthma severities
    FitzGerald, J. Mark
    Kerstjens, Huib
    Pierluigi, Paggia O.
    Ohta, Ken
    Ichinose, Masakazu
    Moroni-Zentgraf, Petra
    Engel, Michael
    Schmidt, Hendrik
    Bateman, Eric
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [23] Once-Daily Tiotropium Respimat® Add-On To Inhaled Corticosteroid Maintenance Therapy Reduces Airflow Obstruction In Patients With Symptomatic Asthma, Independent Of Body Mass Index Score
    Khurana, S.
    Kerstjens, A. M.
    Paggiaro, P.
    Buhl, R.
    Bernstein, J. A.
    Haddon, J.
    Engel, M.
    Unseld, A.
    Casale, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO ICS plus LABA IMPROVES SYMPTOM CONTROL AND REDUCES EXACERBATIONS IN PATIENTS WITH SYMPTOMATIC ASTHMA
    Price, D.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Dahl, R.
    Paggiaro, P.
    Vandewalker, M.
    Kerstjens, H. A. M.
    Kaplan, A.
    THORAX, 2014, 69 : A49 - A50
  • [25] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D.
    Bateman, E. D.
    Paggiaro, P.
    Bleecker, E. R.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2015, 70 : A151 - A151
  • [26] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D. M. G.
    Paggiaro, P.
    Bleecker, E.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2014, 69 : A189 - A189
  • [27] Once-daily tiotropium Respimat add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics
    Casale, Thomas
    Bateman, Eric
    Aalbers, Rene
    Bleecker, Eugene
    Meltzer, Eli
    Voelker, Birgit
    Sigmund, Ralf
    de la Hoz, Alberto
    Kerstjens, Huib
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [28] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH MODERATE SYMPTOMATIC ASTHMA, INDEPENDENT OF T HELPER 2 INFLAMMATORY STATUS
    Vandewalker, M.
    Harper, T., III
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Bernstein, J. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A54 - A55
  • [29] Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics
    Casale, Thomas B.
    Aalbers, Rene
    Bleecker, Eugene R.
    Meltzer, Eli O.
    Zaremba-Pechmann, Liliana
    de la Hoz, Alberto
    Kerstjens, Huib A. M.
    RESPIRATORY MEDICINE, 2019, 158 : 97 - 109
  • [30] Once-Daily Tiotropium Respimat® Add-On Therapy Improves Symptom Control Across Severities Of Symptomatic Asthma, Independent Of Allergic Status
    FitzGerald, J. M.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Bleecker, E. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191